The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Adipocyte-Derived Th2 Cytokines and Myeloid PPARδ Regulate Macrophage Polarization and Insulin Sensitivity
Open accessAbstract
The polarization of adipose tissue-resident macrophages toward the alternatively activated, anti-inflammatory M2 phenotype is believed to improve insulin sensitivity. However, the mechanisms controlling tissue macrophage activation remain unclear. Here we show that adipocytes are a source of Th2 cytokines, including IL-13 and to a lesser extent IL-4, which induce macrophage PPARdelta/beta (Ppard/b) expression through a STAT6 binding site on its promoter to activate alternative activation. Coculture studies indicate that Ppard ablation renders macrophages incapable of transition to the M2 phenotype, which in turns causes inflammation and metabolic derangement in adipocytes. Remarkably, a similar regulatory mechanism by hepatocyte-derived Th2 cytokines and macrophage PPARdelta is found to control hepatic lipid metabolism. The physiological relevance of this paracrine pathway is demonstrated in myeloid-specific PPARdelta(-/-) mice, which develop insulin resistance and show increased adipocyte lipolysis and severe hepatosteatosis. These findings provide a molecular basis to modulate tissue-resident macrophage activation and insulin sensitivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, macrophages that rely on fatty acid metabolism secrete anti-inflammatory cytokines and thus preserve insulin sensitivity of liver and adipose tissue (type M2) (167, 168).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [168]
In the citing paper
“IL-13 is an important main T helper 2 (TH2) cell cytokine that mediates the anti-inflammatory polarization of resident macrophages in WAT135.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [135]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 697
PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs
Peyrou, M., Ramadori, P., Bourgoin, L., & Foti, M. (2012) · PPAR Research · doi:10.1155/2012/757803 · Cited by 65
Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy
Humbert, M., Seiler, K., Mosimann, S., Rentsch, V., Sharma, K., Pandey, A. V., McKenna, S. L., & Tschan, M. P. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00768-1 · Cited by 64
Impact of obesity on autoimmune arthritis and its cardiovascular complications
Raemdonck, K. V., Umar, S., Szekanecz, Z., Zomorrodi, R. K., & Shahrara, S. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.007 · Cited by 66
Adipose tissue insulin action and IL-6 signaling after exercise in obese mice
MACPHERSON, R. E. K., HUBER, J. S., FRENDO-CUMBO, S., SIMPSON, J. A., & WRIGHT, D. C. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000660 · Cited by 62
Kwon, H., Laurent, S., Tang, Y., Zong, H., Vemulapalli, P., & Pessin, J. E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.068 · Cited by 61
Huo, Y., Guo, X., Li, H., Xu, H., Halim, V., Zhang, W., Wang, H., Fan, Y.-Y., Ong, K. T., Woo, S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370379 · Cited by 63
Menn, G. L., & Neels, J. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061575 · Cited by 61
Reilly, S. M., Bhargava, P., Liu, S., Gangl, M. R., Görgün, C. Z., Nofsinger, R. R., Evans, R. M., Qi, L., Hu, F. B., & Lee, C. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.007 · Cited by 58
Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages
Li, X., Guo, X., Ling, J., Tang, Z., Huang, G., He, L., & Chen, T. (2021) · Nanoscale · doi:10.1039/d0nr08050k · Cited by 58
Rao, X., Zhong, J., & Sun, Q. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.09.015 · Cited by 58
Neuroprotective Mechanisms of PPAR δ : Modulation of Oxidative Stress and Inflammatory Processes
Schnegg, C. I., & Robbins, M. E. C. (2011) · PPAR Research · doi:10.1155/2011/373560 · Cited by 60
Interrelation of adipose tissue macrophages and fibrosis in obesity
Dahdah, N., Tercero‐Alcázar, C., Malagón, M. M., García-Rovés, P. M., & Guzmán‐Ruiz, R. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116324 · Cited by 63
Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.02.003 · Cited by 57
Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes
Morris, D. L. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1393 · Cited by 57
Thomas, G. D., Rückerl, D., Maskrey, B. H., Whitfield, P. D., Blaxter, M., & Allen, J. E. (2012) · Blood · doi:10.1182/blood-2012-07-442640 · Cited by 56
Marathe, C., Bradley, M. N., Hong, C., Chao, L. C., Wilpitz, D. C., Salazar, J. V., & Tontonoz, P. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800189-jlr200 · Cited by 56
Cellular crosstalk in fibrosis: Insights into macrophage and fibroblast dynamics
Froom, Z. S. C. S., Callaghan, N. I., & Huyer, L. D. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110203 · Cited by 64
Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
Stöger, J. L., Goossens, P., & de Winther, M. P. J. (2010) · Current Vascular Pharmacology · doi:10.2174/157016110790886983 · Cited by 54
Macrophages, PPARs, and Cancer
Ginderachter, J. A. V., Movahedi, K., den Bossche, J. V., & BAETSELIER, P. D. (2008) · PPAR Research · doi:10.1155/2008/169414 · Cited by 54
PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice
Iglesias, J., Barg, S., Vallois, D., Lahiri, S., Roger, C., Yessoufou, A., Pradevand, S., McDonald, A., Bonal, C., Reimann, F. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci42127 · Cited by 58
Zlotnikov-Klionsky, Y., Nathansohn-Levi, B., Shezen, E., Rosen, C., Kagan, S., Bar‐On, L., Jung, S., Shifrut, E., Reich-Zeliger, S., Friedman, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.015 · Cited by 57
I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis
von Moltke, J., & Locksley, R. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.09.009 · Cited by 57
Bouhlel, M. A., Brozek, J., Derudas, B., Zawadzki, C., Jude, B., Staels, B., & Chinetti, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.047 · Cited by 53
Modulation of Chitotriosidase During Macrophage Differentiation
Rosa, M. D., Malaguarnera, G., Gregorio, C. D., D’Amico, F., Mazzarino, M. C., & Malaguarnera, L. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9471-x · Cited by 53
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 54
Kumamoto, Y., Camporez, J. P., Jurczak, M. J., Shanabrough, M., Horváth, T. L., Shulman, G. I., & Iwasaki, A. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.002 · Cited by 55
Muir, L. A., Kiridena, S., Griffin, C. A., DelProposto, J. B., Geletka, L. M., Martinez-Santibañez, G., Zamarron, B. F., Lucas, H. R., Singer, K., O’Rourke, R. W., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi1017-422r · Cited by 56
Mechanism of Interleukin-4 Reducing Lipid Deposit by Regulating Hormone-Sensitive Lipase
Shiau, M., Chuang, P.-H., Yang, C.-P., Hsiao, C., Chang, S., Chang, K.-Y., Liu, T.-M., Chen, H. A., Chuang, C.-C., Yuan, S.-Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47908-9 · Cited by 52
Macrophages as key regulators of liver health and disease
Papachristoforou, E., & Ramachandran, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.006 · Cited by 56
Neurolysin Knockout Mice Generation and Initial Phenotype Characterization
Cavalcanti, D. M. L. D. P., de Castro, L. M., Neto, J. C. R., Seelaender, M. C. L., das Neves, R. X., Oliveira, V., Forti, F. L., Iwai, L. K., Gozzo, F. C., Todiraş, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.539148 · Cited by 52
Stöhr, R., & Federici, M. (2013) · Biochemical Journal · doi:10.1042/bj20130121 · Cited by 51
Bojic, L. A., Burke, A. C., Chhoker, S. S., Telford, D. E., Sutherland, B. G., Edwards, J. Y., Sawyez, C. G., Tirona, R. G., Yin, H., Pickering, J. G., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301830 · Cited by 53
Regulation of immunometabolism in adipose tissue
Kumari, M., Heeren, J., & Scheja, L. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0668-3 · Cited by 53
IL-10 Function, Regulation, and in Bacterial Keratitis
Hazlett, L. D., Jiang, X., & McClellan, S. A. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0018 · Cited by 54
Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Pan, J., Zhou, W., Xu, R., Xing, L., Ji, G., & Dang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113127 · Cited by 50
Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance
Caratti, G., Stifel, U., Caratti, B., Jamil, A. J. M., Chung, K., Kiehntopf, M., Gräler, M. H., Blüher, M., Rauch, A., & Tuckermann, J. P. (2023) · Nature Communications · doi:10.1038/s41467-023-37831-z · Cited by 52
Ambrožová, G., Martiskova, H., Koudelka, A., Ravekes, T., Rudolph, T. K., Klinke, A., Rudolph, V., Freeman, B. Α., Woodcock, S. R., Kubala, L., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.026 · Cited by 49
Folate Receptor-β in Activated Macrophages: Ligand Binding and Receptor Recycling Kinetics
Varghese, B., Vlashi, E., Xia, W. G., Ayala-López, W., Paulos, C. M., Reddy, J. A., Xu, L., & Low, P. S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500348e · Cited by 50
Tellechea, M., Buxadé, M., Vaquero, S. T., Aramburu, J. F., & López‐Rodríguez, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601942 · Cited by 51
Metabolic and Molecular Mechanisms of Macrophage Polarisation and Adipose Tissue Insulin Resistance
Orliaguet, L., Ejlalmanesh, T., & Alzaïd, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165731 · Cited by 53
Zhang, B., Miao, T., Shen, X., Bao, L., Zhang, C., Yan, C., Wei, W., Chen, J., Xiao, L., Sun, C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02925-9 · Cited by 50
Adipose tissue plasticity and the pleiotropic roles of BMP signaling
Qian, S., Tang, Y., & Tang, Q. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100678 · Cited by 56
Blood spotlight on leukocytes and obesity
Carvalheira, J. B. C., Qiu, Y., & Chawla, A. (2013) · Blood · doi:10.1182/blood-2013-04-459446 · Cited by 50
Saha, B., Bala, S., Hosseini, N., Kodys, K., & Szabó, G. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a1014-485r · Cited by 51
Kanakasabai, S., Walline, C. C., Chakraborty, S., & Bright, J. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.059 · Cited by 49
Tumor-Associated Macrophages: Combination of Therapies, the Approach to Improve Cancer Treatment
Moeini, P., & Niedźwiedzka‐Rystwej, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137239 · Cited by 50
A Macrophage NBR1-MEKK3 Complex Triggers JNK-Mediated Adipose Tissue Inflammation in Obesity
Hernandez, E. D., Lee, S. J., Kim, J. Y., Durán, Á., Linares, J. F., Yajima, T., Müller, T. D., Tschöp, M. H., Smith, S. R., Díaz-Meco, M. T., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.008 · Cited by 49
The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity
Yasui, M., Tamura, Y., Minami, M., Higuchi, S., Fujikawa, R., Ikedo, T., Nagata, M., Arai, H., Murayama, T., & Yokode, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136304 · Cited by 50
Wan, L., Lin, H.-J., Huang, C.-C., Chen, Y., Hsu, Y.-A., Lin, C.-H., Lin, H.-C., Chang, C.-Y., Huang, S., Lin, J.-M., et al. (2016) · Glycobiology · doi:10.1093/glycob/cww013 · Cited by 48
Sudhakaran, M., & Doseff, A. I. (2020) · Molecules · doi:10.3390/molecules25112477 · Cited by 49
The relationship between inflammatory markers, angiogenesis, and obesity.
Tahergorabi, Z., & Khazaei, M. (2013) · Europe PMC (PubMed Central) · Cited by 46
Li, L., Luo, Z., Yu, H., Feng, X., Wang, P., Chen, J., Pu, Y., Zhao, Y. C., He, H., Zhong, J., et al. (2012) · Diabetes · doi:10.2337/db12-0570 · Cited by 47
Adipocytes Modulate the Phenotype of Human Macrophages through Secreted Lipids
Klein‐Wieringa, I. R., Andersen, S. N., Kwekkeboom, J. C., Giera, M. A., de Lange-Brokaar, B. J. E., van Osch, G. J. V. M., Zuurmond, A., Stojanovic-Susulic, V., Nelissen, R. G. H. H., Pijl, H., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203074 · Cited by 48
Müller, R. (2016) · Biochimie · doi:10.1016/j.biochi.2016.10.019 · Cited by 47
Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links
Hopkin, J. M. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01104.x · Cited by 47
Zhang, Y., Li, C., Yao, G.-F., Du, L., Liu, Y., Zheng, X., Yan, S., Sun, J., Liu, Y., Liu, M., et al. (2017) · Diabetes · doi:10.2337/db16-1354 · Cited by 45
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
Hundertmark, J., Krenkel, O., & Tacke, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02418 · Cited by 46
Miki, Y., Taketomi, Y., Kidoguchi, Y., Yamamoto, K., Muramatsu, K., Nishito, Y., Park, J., Hosomi, K., Mizuguchi, K., Kunisawa, J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.152611 · Cited by 45
Tsai, Y.-W., Lu, C., Chang, R. C.-A., Hsu, Y.-P., Ho, L.-T., & Shih, K. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102270 · Cited by 44
Hagita, S., Osaka, M., Shimokado, K., & Yoshida, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019871 · Cited by 44
Adipose tissue signaling by nuclear receptors in metabolic complications of obesity
Jacobi, D., Stanya, K. J., & Lee, C. (2012) · Adipocyte · doi:10.4161/adip.19036 · Cited by 45
The role of macrophages in obesity-driven chronic liver disease
Devisscher, L., Verhelst, X., Colle, I. O., Vlierberghe, H. V., & Geerts, A. M. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ru0116-016r · Cited by 46
Zhao, X., Zhang, J., Li, C., Kuang, W., Deng, J., Tan, X., Li, C., & Li, S. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101975 · Cited by 47
A role for PFKFB3/iPFK2 in metformin suppression of adipocyte inflammatory responses
Qi, T., Chen, Y., Li, H., Pei, Y., Woo, S., Guo, X., Zhao, J., Qian, X., Awika, J. M., Huo, Y., et al. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0066 · Cited by 44
Chatzigeorgiou, A., & Chavakis, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_8 · Cited by 44
Physiology of RGS10 in Neurons and Immune Cells
Lee, J., & Tansey, M. G. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.01.005 · Cited by 41
Naruhn, S., Toth, P. M., Adhikary, T., Kaddatz, K., Pape, V. F. S., Dörr, S., Klebe, G., Müller‐Brüsselbach, S., Diederich, W. E., & Müller, R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074039 · Cited by 42
Pradhan, B., Guha, D., Ray, P., Das, D., & Aich, P. (2016) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-016-9211-4 · Cited by 42
Dasgupta, A., Bandyopadhyay, G. K., Ray, I., Bandyopadhyay, K., Chowdhury, N., De, R. K., & Mahata, S. K. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.02.005 · Cited by 41
Zhang, C., Dong, L., Wu, J., Qiao, S., Xu, W., Ma, S., Zhao, B., & Wang, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110350 · Cited by 41
CD1d-dependent rewiring of lipid metabolism in macrophages regulates innate immune responses
Brailey, P. M., Evans, L., López‐Rodríguez, J. C., Sinadinos, A., Tyrrell, V. J., Kelly, G. P., O’Donnell, V. B., Ghazal, P., John, S., & Barral, P. (2022) · Nature Communications · doi:10.1038/s41467-022-34532-x · Cited by 40
Key biomarkers in type 2 diabetes patients: A systematic review
Le, T. N., Bright, R., Truong, V. K., Li, J. Y. Z., Juneja, R., & Vasilev, K. A. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15991 · Cited by 46
Targeting PPARβ/δ for the treatment of type 2 diabetes mellitus
Salvadó, L., Serrano, L., Barroso, E., Palomer, X., & Vázquez‐Carrera, M. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.658370 · Cited by 42
Metabolic regulation of suppressive myeloid cells in cancer
Sica, A., Strauss, L., Consonni, F. M., Travelli, C., Genazzani, A. A., & Porta, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.05.002 · Cited by 40
PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration
Choudhary, M., Ding, J.-D., Qi, X., Boulton, M. E., Yao, P.-L., Peters, J. M., & Malek, G. (2016) · Aging · doi:10.18632/aging.101031 · Cited by 39
Singh, A., & Chaudhary, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114616 · Cited by 42
Adaptive Immunity and Antigen‐Specific Activation in Obesity‐Associated Insulin Resistance
Chng, M. H. Y., Alonso, M. N., Barnes, S. E., Nguyen, K. D., & Engleman, E. G. (2015) · Mediators of Inflammation · doi:10.1155/2015/593075 · Cited by 39
Xu, Y., Kume, S., Tanaka, Y., Isshiki, K., Araki, S., Chin‒Kanasaki, M., Sugimoto, T., Koya, D., Haneda, M., Sugaya, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025271 · Cited by 40
Loss of macrophage fatty acid oxidation does not potentiate systemic metabolic dysfunction
Gonzalez-Hurtado, E., Lee, J.-E., Choi, J., Alpergin, E. S. S., Collins, S. L., Horton, M. R., & Wolfgang, M. J. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2016 · Cited by 39
Ziegler, J., Böttcher, C., Letizia, M., Yerinde, C., Wu, H., Freise, I., Rodriguez‐Sillke, Y., Stoyanova, A. K., Kreis, M. E., Asbach, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13559-7 · Cited by 39
Implications of metabolism-driven myeloid dysfunctions in cancer therapy
Strauss, L., Guarneri, V., Gennari, A., & Sica, A. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00556-w · Cited by 39
Contributions of innate type 2 inflammation to adipose function
Bolus, W. R., & Hasty, A. H. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r085993 · Cited by 42
Nuclear receptors, the aryl hydrocarbon receptor, and macrophage function
Lamorte, S., Shinde, R. S., & McGaha, T. L. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100942 · Cited by 37
Targeting PPARs for therapy of atherosclerosis: A review
Miao, M., Wang, X., Liu, T., Li, Y., Yu, W., Yang, T.-M., & Guo, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125008 · Cited by 40
Nuclear hormone receptors in diabetic nephropathy
Wang, X. X., Jiang, T., & Levi, M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.56 · Cited by 37
Peroxisome Proliferator‐Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease
Mello, T., Polvani, S., & Galli, A. (2009) · PPAR Research · doi:10.1155/2009/748174 · Cited by 38
PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets
Zheng, Y., Shao, M., Zheng, Y., Sun, W., Qin, S., Sun, Z., Zhu, L., Guan, Y., Wang, Q., Wang, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.020 · Cited by 41
Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation
Manteiga, S., Choi, K., Jayaraman, A., & Lee, K. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1213 · Cited by 38
PPARβ in macrophages and atherosclerosis
Chinetti, G., & Staels, B. (2016) · Biochimie · doi:10.1016/j.biochi.2016.12.008 · Cited by 37
MicroRNA regulated macrophage activation in obesity
Li, C., Qu, L., Farragher, C., Vella, A. T., & Zhou, B. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0011 · Cited by 38
Retinoid X Receptor Heterodimer Variants and Cardiovascular Risk Factors
Nohara, A., Kobayashi, J., & Mabuchi, H. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.no786 · Cited by 38
Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury
Esposito, E., & Cuzzocrea, S. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.581231 · Cited by 38
Zhang, Y., Zhao, Y., Zhang, J., Gao, Y., Li, S., Chang, C., Yu, D., & Yang, G. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136206 · Cited by 36
Liu, L., Xiao, F., Sun, J. L., Wang, Q., Wang, A., Zhang, F., Li, Z., Wang, X., Fang, Z., & Qiao, Y. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110060 · Cited by 40
Fat Stress and Liver Resistance
Ogawa, W., & Kasuga, M. (2008) · Science · doi:10.1126/science.1167571 · Cited by 36
Mitochondrial metabolism, reactive oxygen species, and macrophage function-fishing for insights
Hall, C. J., Sanderson, L. E., Crosier, K. E., & Crosier, P. S. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1186-6 · Cited by 37
Fang, X., Zou, S., Zhao, Y., Cui, R., Zhang, W., Hu, J., & Dai, J. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0877-4 · Cited by 37
Peroxisome proliferator-activated receptor delta and cardiovascular disease
Ehrenborg, E., & Skogsberg, J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.027 · Cited by 36
Fujisaka, S., Usui, I., Nawaz, A., Takikawa, A., Kado, T., Igarashi, Y., & Tobe, K. (2016) · Diabetology International · doi:10.1007/s13340-016-0290-y · Cited by 39
PPARβ/δ-dependent MSC metabolism determines their immunoregulatory properties
Contreras-López, R. A., Elizondo-Vega, R. J., Torres, M. J., Vega-Letter, A. M., Luque‐Campos, N., Paredes-Martínez, M. J., Pradenas, C., Téjédor, G., Oyarce, K., Salgado, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68347-x · Cited by 37
Metadata
- Authors
- Kang, K., Reilly, S. M., Karabacak, V., Gangl, M. R., Fitzgerald, K., Hatano, B., & Lee, C.-H.
- Affiliations
- Harvard University (US)
- Corresponding author
- Lee, Chih-Hao
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 7
- Issue
- 6
- Pages
- 485-495
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2586840
- OpenAlex
- W2046935888
- Cited by
- 699
- References
- 41
- Citations by year
- 2026: 14 · 2025: 24 · 2024: 25 · 2023: 21 · 2022: 25 · 2021: 44 · 2020: 42 · 2019: 32 · 2018: 39 · 2017: 40 · 2016: 43 · 2015: 46 · 2014: 40 · 2013: 76 · 2012: 51
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5t32es007155-24)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK34845, R90DK071507, R01DK075046, P30DK034854)
- National Institute of Environmental Health Sciences (T32-ES07155, T32-ES007155, T32ES016645)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- adipose tissue macrophages, macrophage polarization, M2 phenotype, Th2 cytokines, IL-13, IL-4, PPARδ, STAT6, adipocytes, hepatocytes, insulin sensitivity, insulin resistance, hepatic lipid metabolism, hepatic steatosis, adipocyte lipolysis, paracrine signaling, myeloid-specific knockout
- MeSH terms
- Animals, Gene Expression Regulation, Inflammation, Insulin Resistance, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Cytokines, Adipocytes, Mice, Knockout, Th2 Cells, Coculture Techniques, Paracrine Communication, Hepatocytes, PPAR delta, PPAR-beta, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review